MATHEW ABY J. (EVP & Chief Scientific Officer) reported 1 transaction at BIOLIFE SOLUTIONS INC
Review the transaction codes below to understand the nature of each event.
Filed: 7/13/2026ACC: 0001628280-26-048053
Officer· EVP & Chief Scientific Officer
Since Mar 2026
-516.00
Net shares
Net seller
$14.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
516.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−516.00
Price / share
$27.79
Trade value
$14.34K
% of position
0.1%
7/7/2026
388.98K→388.46K
Total
Net shares
−516.00
Net value
-$14.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/7/2026 | F · Tax Withholding | −516.00 | $27.79 | $14.34K | 0.1% | 388.98K | 388.46K |
| Total | −516.00 | -$14.34K | ||||||
Derivative Transactions0
No derivative transactions reported